Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | MEDP | HQY | ||
| Company | Charles River Laboratories Intl | Medpace Holdings Inc | Healthequity | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 185.84 | 308.53 | 101.25 | ||
| High | 188.38 | 318.84 | 102.75 | ||
| Low | 183.91 | 305.88 | 99.90 | ||
| Last | 186.10 | 314.96 | 102.67 | ||
| Change | -1.40 | +6.03 | +0.27 | ||
| % Change | -0.75% | +1.95% | +0.26% | ||
| Volume | 714,400 | 679,300 | 640,700 | ||
| 20-Day Average Volume | 888,955 | 402,255 | 745,095 | ||
| Previous Close | 187.50 | 308.93 | 102.40 | ||
| Industry | Medical Services | Medical Services | Medical Services | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 193.77 | 333.80 | 93.06 | ||
| 20-Day Raw Stochastic | 17.97% | 18.88% | 97.55% | ||
| 20-Day Relative Strength | 44.22% | 41.50% | 70.77% | ||
| Weighted Alpha | -14.22 | -1.99 | +57.01 | ||
| Today's Opinion | 96% Sell | 96% Sell | 100% Buy | ||
| Previous Opinion | 96% Sell | 96% Sell | 100% Buy | ||
| Last Month's Opinion | 88% Sell | 72% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.82% since 11/12/24 | -12.71% since 11/12/24 | +2.47% since 11/12/24 | ||
| Low | 183.35 on 11/15/24 | 302.08 on 11/18/24 | 94.32 on 11/13/24 | ||
| High | 217.75 on 11/13/24 | 366.98 on 11/13/24 | 103.12 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | -5.90% since 10/18/24 | -11.63% since 10/18/24 | +17.10% since 10/18/24 | ||
| Low | 176.48 on 10/31/24 | 302.01 on 10/22/24 | 84.78 on 11/04/24 | ||
| High | 230.02 on 11/06/24 | 370.31 on 11/08/24 | 103.12 on 11/18/24 | ||
| 3-Month | |||||
| %Chg | -8.78% since 08/19/24 | -19.66% since 08/19/24 | +35.59% since 08/19/24 | ||
| Low | 176.48 on 10/31/24 | 302.01 on 10/22/24 | 73.63 on 08/21/24 | ||
| High | 230.02 on 11/06/24 | 397.06 on 08/22/24 | 103.12 on 11/18/24 | ||
| 6-Month | |||||
| %Chg | -16.02% since 05/17/24 | -19.92% since 05/17/24 | +29.62% since 05/17/24 | ||
| Low | 176.48 on 10/31/24 | 302.01 on 10/22/24 | 65.01 on 08/05/24 | ||
| High | 254.15 on 08/01/24 | 459.77 on 07/17/24 | 103.12 on 11/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,588,000 | 9,602,162 | 8,941,977 | ||
| Shares Outstanding, K | 51,136 | 31,082 | 87,324 | ||
| Annual Sales | 4,129,410,000 | 1,885,840,000 | 999,590,000 | ||
| Annual Net Income | 474,620,000 | 282,810,000 | 55,710,000 | ||
| Last Quarter Sales | 1,009,760,000 | 533,320,000 | 299,930,000 | ||
| Last Quarter Net Income | 69,280,000 | 96,430,000 | 35,820,000 | ||
| 60-Month Beta | 1.38 | 1.37 | 0.52 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.59 on 11/06/24 | 3.01 on 10/21/24 | 0.86 on 09/03/24 | ||
| Latest Earnings Date | 11/06/24 | 10/21/24 | 12/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 18.55 | 27.20 | 46.91 | ||